French pharma manufacturer scaling production and regulatory infrastructure globally
Mayoly is a century-old, family-owned French pharmaceutical and dermatology company with over 1,000 employees and manufacturing footprint across France and Mexico. The tech stack reveals a classic pharma ops pattern: Veeva CRM for regulatory workflows, IQVIA for market intelligence, and IBM TM1/Qlik for manufacturing analytics—paired with heavy adoption of Microsoft 365 and Windows 11, signaling infrastructure modernization. Active hiring in engineering, manufacturing, and operations across mid and manager levels suggests they're scaling production systems while addressing documented pain points in cybersecurity, regulatory compliance, and application rationalization.
Mayoly manufactures and distributes pharmaceuticals and dermo-cosmetic products across gastroenterology, rheumatology, ENT, and consumer health segments. The company owns manufacturing facilities in France and operates subsidiaries internationally, controlling its own production tooling and supply chain. Core brands include Topicrem and Charlieu in the dermo-cosmetics space. The business is structured around regulatory compliance, product innovation (OTC launches underway), and industrial cost control. Leadership priorities center on talent development and global expansion of consumer healthcare offerings.
Mayoly runs IBM TM1, QlikView, Qlik Sense, and Power BI for manufacturing analytics and dashboards; Veeva CRM for regulatory workflows; IQVIA for market intelligence; and Snowflake with dbt for data pipelines. Active projects include Power BI dashboard development for industrial sites.
Documented priorities include modernizing IT infrastructure, improving industrial cybersecurity, consolidating production costs, ensuring HSE and customs regulatory compliance, and rationalizing their application portfolio. Current projects address risk management, sustainability, and CRM implementation.
Other companies in the same industry, closest in size